University of Utah College of Nursing, Salt Lake City, UT, USA.
University of Utah School of Medicine, Salt Lake City, UT, USA.
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241282862. doi: 10.1177/21501319241282862.
The Diabetes Prevention Program (DPP) is effective; enrollment is low. Little research has examined factors driving individuals' enrollment decisions.
In our final survey of a randomized trial comparing methods to increase enrollment in the DPP, we asked participants about factors impacting enrollment. We conducted interviews with a subgroup.
Participants who completed the survey (n = 299) were primarily female (96 male); middle-aged (mean 52.9, SD = 14.7); white (86%); non-Hispanic (85%). Only 19% reported awareness of the DPP prior to the study. Cost, online availability, and behavior-change motivation were the most highly rated factors influencing enrollment. The median amount participants were willing to pay for the program was $66.50. Phone interviews included 17 individuals who were/were not interested in receiving a referral to the DPP. Those interested described risk awareness, family history, social support, and healthcare-provider influence as facilitating enrollment. Cost, time, travel, unsupportive family, incomplete knowledge about the program's impact and low self-efficacy were barriers. Among those uninterested, some were already engaging in lifestyle change, and some didn't see a benefit.
Results suggest that, even among high-risk individuals, efforts to increase awareness and benefits of the DPP are needed, as are efforts to address cost of enrollment and low motivation.
ClinicalTrials.gov protocol ID: 00132307. The Effect of 360 Video and MAPS on Enrollment in the DPP. URL: https://www.clinicaltrials.gov/study/NCT04746781?id=00132307&rank=1.
糖尿病预防计划(DPP)有效;但参与率低。很少有研究探讨影响个人参与决策的因素。
在我们对一项比较增加 DPP 参与率方法的随机试验的最终调查中,我们询问了参与者影响参与的因素。我们对一个亚组进行了访谈。
完成调查的参与者(n=299)主要为女性(96 名男性);中年(平均 52.9,标准差=14.7);白人(86%);非西班牙裔(85%)。只有 19%的人在研究前就知道 DPP。成本、在线可用性和行为改变动机是影响参与率的最重要因素。参与者愿意为该计划支付的中位数金额为 66.50 美元。电话访谈包括 17 名对接受 DPP 转介感兴趣和不感兴趣的人。感兴趣的人描述了风险意识、家族史、社会支持和医疗保健提供者的影响,这些都有助于参与。成本、时间、旅行、不支持的家庭、对该计划影响的不完全了解和低自我效能感是障碍。对那些不感兴趣的人来说,有些人已经在改变生活方式,有些人则认为没有好处。
结果表明,即使在高风险人群中,也需要努力提高对 DPP 的认识和益处,还需要努力解决参与成本和低动机的问题。
ClinicalTrials.gov 协议 ID:00132307。360 度视频和 MAPS 对 DPP 参与的影响。网址:https://www.clinicaltrials.gov/study/NCT04746781?id=00132307&rank=1。